Religrast 300mcg Injection

Religrast 300mcg Injection belongs to the class of medicine called 'hematopoietic agent' used to treat neutropenia, a lack of certain white blood cells caused by cancer, bone marrow transplant, receiving chemotherapy, bacterial infections or other conditions. Neutropenia is a condition in which the number of neutrophils (a type of white blood cell) in the blood is decreased. White blood cells (neutrophils) protect the body from infections. Without enough neutrophils, the body can not fight off bacteria which increases the risk of many types of infections.

Religrast 300mcg Injection contains ' Filgrastim ' that stimulates the bone marrow (the tissue where new blood cells are made) to produce more white blood cells that help fight infection. Religrast 300mcg Injection is used to improve white blood cells during cancer treatment (chemotherapy), bone marrow transplantation, severe chronic neutropenia (low number of a type of white blood cells), neutropenia in patients with HIV infection, and before stem cell donation.

You are advised to take Religrast 300mcg Injection for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience certain common side effects such as thrombocytopenia (low platelets level), anaemia (low red blood cell), headache, diarrhoea, vomiting, nausea, alopecia (unusual hair loss), tiredness, soreness, swelling of the digestive tract, fever. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

To treat your condition effectually, continue taking Religrast 300mcg Injection for as long as your doctor has prescribed. To avoid recurring symptoms, do not stop it midway. Do not take Religrast 300mcg Injection if you are pregnant or planning for pregnancy. Religrast 300mcg Injection should not be taken by breastfeeding mothers unless prescribed. Religrast 300mcg Injection should be given to children under strict medical supervision. Please tell your doctor before using Religrast 300mcg Injection if you have sickle cell anaemia, as Religrast 300mcg Injection may cause sickle cell crisis and osteoporosis (bone disease). Regular blood tests will be taken to monitor the number of white blood cells in the body. Inform your doctor about your health condition and medicines to rule out unpleasant side effects. Religrast 300mcg Injection is a cold chain medicine, and so it has to be stored in the refrigerator between 2-8 degrees celsius else its efficacy might get lost. Do not store in the freezer or the fridge.

Religrast 300mcg Injection is used in the treatment of neutropenia (low neutrophil count). The detailed uses of Religrast 300mcg Injection are as follows:

• Treats and Prevents Chemotherapy-Induced Neutropenia: Religrast 300mcg Injection is used to treat and prevent neutropenia in patients receiving myelosuppressive anticancer medications, thereby reducing the risk of infection.
• Treats Severe Chronic Neutropenia: Religrast 300mcg Injection is prescribed for patients with chronic neutropenia (such as congenital, cyclic, or idiopathic types) to boost neutrophil production and prevent recurrent infections.
• Supports Recovery After Bone Marrow Transplant: Religrast 300mcg Injection helps shorten the duration of neutropenia and prevents related complications (such as fever and infection) following bone marrow transplantation.
• Mobilizes Stem Cells for Collection: Religrast 300mcg Injection is used to stimulate the release of hematopoietic stem cells from the bone marrow into the bloodstream, making them easier to collect for stem cell transplantation.
• Manages Neutropenia in HIV Patients: Religrast 300mcg Injection may be used to restore white blood cell counts in HIV patients with neutropenia, thereby reducing their risk of acquiring infections.